Liu, Ya-Nan <br/><br/>
A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  03 2020 
 - 555-562 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-019-04014-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous--methods<br/>Adolescent<br/>Adult<br/>Antineoplastic Agents, Immunological--pharmacokinetics<br/>Area Under Curve<br/>Bevacizumab--pharmacokinetics<br/>Biosimilar Pharmaceuticals--pharmacokinetics<br/>Double-Blind Method<br/>Healthy Volunteers<br/>Humans<br/>Male<br/>Therapeutic Equivalency<br/>Young Adult